Virtus ETF Advisers’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-4,143
| Closed | -$61.7K | – | 580 |
|
|
2024
Q4 | $61.7K | Sell |
4,143
-1,281
| -24% | -$19.1K | 0.03% | 441 |
|
|
2024
Q3 | $82.9K | Buy |
5,424
+99
| +2% | +$1.51K | 0.04% | 411 |
|
|
2024
Q2 | $81.1K | Buy |
5,325
+414
| +8% | +$6.31K | 0.04% | 401 |
|
|
2024
Q1 | $92.7K | Sell |
4,911
-340
| -6% | -$6.42K | 0.05% | 375 |
|
|
2023
Q4 | $100K | Buy |
5,251
+209
| +4% | +$3.99K | 0.06% | 358 |
|
|
2023
Q3 | $90.5K | Sell |
5,042
-506
| -9% | -$9.08K | 0.06% | 347 |
|
|
2023
Q2 | $113K | Buy |
5,548
+2,538
| +84% | +$51.5K | 0.07% | 340 |
|
|
2023
Q1 | $54.9K | Sell |
3,010
-1,156
| -28% | -$21.1K | 0.03% | 427 |
|
|
2022
Q4 | $86.2K | Sell |
4,166
-902
| -18% | -$18.7K | 0.05% | 442 |
|
|
2022
Q3 | $133K | Buy |
5,068
+39
| +0.8% | +$1.02K | 0.05% | 372 |
|
|
2022
Q2 | $127K | Buy |
5,029
+1,075
| +27% | +$27.1K | 0.05% | 365 |
|
|
2022
Q1 | $125K | Sell |
3,954
-225
| -5% | -$7.11K | 0.06% | 256 |
|
|
2021
Q4 | $169K | Sell |
4,179
-4,485
| -52% | -$181K | 0.06% | 291 |
|
|
2021
Q3 | $302K | Sell |
8,664
-447
| -5% | -$15.6K | 0.13% | 200 |
|
|
2021
Q2 | $250K | Sell |
9,111
-237
| -3% | -$6.5K | 0.1% | 210 |
|
|
2021
Q1 | $262K | Buy |
9,348
+160
| +2% | +$4.48K | 0.11% | 278 |
|
|
2020
Q4 | $239K | Sell |
9,188
-1,887
| -17% | -$49.1K | 0.1% | 326 |
|
|
2020
Q3 | $190K | Sell |
11,075
-1,524
| -12% | -$26.1K | 0.1% | 303 |
|
|
2020
Q2 | $312K | Buy |
+12,599
| New | +$312K | 0.15% | 295 |
|
|
2018
Q4 | – | Sell |
-28,669
| Closed | -$400K | – | 363 |
|
|
2018
Q3 | $400K | Sell |
28,669
-21,065
| -42% | -$294K | 0.04% | 160 |
|
|
2018
Q2 | $609K | Buy |
+49,734
| New | +$609K | 0.54% | 131 |
|